(Hypertension. 2000;35:1092.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.
Correspondence to Kenichi Yasunari, MD, First Department of Internal Medicine, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545-8586, Japan.
AbstractWe examined involvement of the polyol pathway in high glucoseinduced human coronary artery smooth muscle cell (SMC) migration using Boydens chamber method. Chronic glucose treatment for 72 hours potentiated, in a concentration-dependent manner (5.6 to 22.2 mol/L), platelet-derived growth factor (PDGF) BBmediated SMC migration. This potentiation was accompanied by an increase in PDGF BB binding, because of an increased number of PDGF-ß receptors, and this potentiation was blocked by the aldose reductase inhibitor epalrestat. Epalrestat at concentrations of 10 and 100 nmol/L inhibited high glucosepotentiated (22.2 mmol/L), PDGF BBmediated migration. Epalrestat at 100 nmol/L inhibited a high glucoseinduced increase in the reduced/oxidized nicotinamide adenine dinucleotide ratio and membrane-bound protein kinase C (PKC) activity in SMCs. PKC inhibitors calphostin C (100 nmol/L) and chelerythrine (1 µmol/L) each inhibited high glucoseinduced, PDGF BBmediated SMC migration. High glucoseinduced suppression of insulin-mediated [3H]-deoxyglucose uptake, which was blocked by both calphostin C (100 nmol/L) and chelerythrine (1 µmol/L), was decreased by epalrestat (100 nmol/L). Chronic high glucose treatment for 72 hours increased intracellular oxidative stress, which was directly measured by flow cytometry using carboxydichlorofluorescein diacetate bis-acetoxymethyl ester, and this increase was significantly suppressed by epalrestat (100 nmol/L). Antisense oligonucleotide to PKC-ß isoform inhibited high glucosemediated changes in SMC migration, insulin-mediated [3H]-deoxyglucose uptake, and oxidative stress. These findings suggest that high glucose concentrations potentiate SMC migration in coronary artery and that the aldose reductase inhibitor epalrestat inhibits high glucosepotentiated, PDGF BBinduced SMC migration, possibly through suppression of PKC (PKC-ß), impaired insulin-mediated glucose uptake, and oxidative stress.
Key Words: pathway, polyol protein kinases oxidative stress insulin resistance atherosclerosis
This article has been cited by other articles:
![]() |
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth Endocrinology, September 1, 2007; 148(9): 4371 - 4384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campbell and E. R. Trimble Modification of PI3K- and MAPK-Dependent Chemotaxis in Aortic Vascular Smooth Muscle Cells by Protein Kinase C{beta}II Circ. Res., February 4, 2005; 96(2): 197 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campbell, W. E. Allen, J. A. Silversides, and E. R. Trimble Glucose-Induced Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase-Dependent Upregulation of the Platelet-Derived Growth Factor-{beta} Receptor Potentiates Vascular Smooth Muscle Cell Chemotaxis Diabetes, February 1, 2003; 52(2): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Slevin, S. Kumar, and J. Gaffney Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses J. Biol. Chem., October 18, 2002; 277(43): 41046 - 41059. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |